Journey Biosciences
Greg Dooley is an experienced finance leader currently serving as Vice President of Strategic Growth Initiatives and Vice President Finance for Latin America at The Goodyear Tire & Rubber Company since January 2019, overseeing all finance activities in the region and collaborating with leadership teams to develop business strategies. Dooley also holds board positions at Journey Biosciences, Inc., and Beyond Type 1, contributing to innovative solutions in biotechnology and diabetes management. Additionally, as Co-Founder and CFO of Estrela Consulting, guidance is provided to families navigating college applications. Previously, Dooley has held various leadership roles within Goodyear, including Finance Director positions in Mexico and Argentina, and was instrumental in corporate financial planning and analysis efforts. A graduate of the Weatherhead School of Management at Case Western Reserve University with an MBA in Finance, and Hiram College, where a BA in Management and Economics was obtained, Dooley combines extensive industry experience with strong educational credentials.
This person is not in the org chart
This person is not in any teams
Journey Biosciences
✨ Journey Biosciences is on a mission to shift the future of care. 🧬 Our flagship solution blends the precision of NaviDKD®, a clinically-validated predictive screening, with the AI-driven insights of Compass™, to offer up to 12 years of advanced diabetes-related kidney disease (DKD) detection, plus tailored intervention strategies to slow or prevent progression. 🎯 This approach improves patient outcomes, optimizes resource allocation, and reduces costs. 🔍 Discover more about our transformative approach at journeybio.life.